Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > VBIV VBI Vaccines > Detailed Quotes

VBIV VBI Vaccines

0.7060.0000.00%
Close 10/03 16:00 ET
High
0.740
Open
0.720
Turnover
555.38K
Low
0.672
Pre Close
0.706
Volume
795.67K
Market Cap
182.36M
P/E(TTM)
Loss
52wk High
3.415
Shares
258.26M
P/E(Static)
Loss
52wk Low
0.641
Float Cap
135.20M
Bid/Ask %
81.82%
Historical High
114.000
Shs Float
191.48M
Volume Ratio
1.21
Historical Low
0.400
Dividend TTM
--
Div Yield TTM
--
P/B
1.73
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.42%
Amplitude
9.63%
Avg Price
0.698
Lot Size
1
Float Cap
135.20M
Bid/Ask %
81.82%
Historical High
114.000
Shs Float
191.48M
Volume Ratio
1.21
Historical Low
0.400
Dividend TTM
--
P/B
1.73
Dividend LFY
--
Turnover Ratio
0.42%
Amplitude
9.63%
Avg Price
0.698
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
VBI Vaccines, Inc. is a biopharmaceutical company, which engages in the development of infectious disease and immuno-oncology vaccines. The firm focuses on the prevention and treatment of hepatitis B through its product pipeline, Sci-B-Vac and VBI-2601. It also develops an enveloped virus-like particle (eVLP) platform technology, which allows the development of eVLP vaccines that closely mimic the target virus to elicit a potent immune response. The company was founded on April 9, 1965 and is headquartered in Cambridge, MA.
CEO: Mr. Jeffrey R. Baxter
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...